NAFLD

Metabolic·MeSH: Non-alcoholic Fatty Liver Disease

6 drugs in development·6 companies·5 clinical trials

Drug Pipeline by Phase

Phase 2(2)

Drug	Company
axa1957	Axcella Health Inc. (AXLA)
VK2809	Viking Therapeutics, Inc. (VKTX)

Preclinical(3)

Drug	Company
AGTX-2003 (RTI-1092769)	Agentix Corp. (AGTX)
hydrogel candidates for nafld/nash	GELESIS HOLDINGS, INC. (GLS)
jkb-122	Biostax Corp. (BTAX)

Unknown(1)

Drug	Company
legalon	Mylan II B.V. (MYL)

BioSniper tracks 6 drugs in development for NAFLD across 6 companies.

There are 5 clinical trials targeting NAFLD tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.